metricas
covid
Buscar en
Enfermería Clínica
Toda la web
Inicio Enfermería Clínica Change in Mean Arterial Pressure (MAP), Roll Over Test (ROT), and Soluble Fms Le...
Información de la revista
Vol. 30. Núm. S6.
The 4th International Conference Hospital Administration (ICHA4)
Páginas 325-330 (octubre 2020)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 30. Núm. S6.
The 4th International Conference Hospital Administration (ICHA4)
Páginas 325-330 (octubre 2020)
Change in Mean Arterial Pressure (MAP), Roll Over Test (ROT), and Soluble Fms Level like Tyrosine Kinase-1 (SFLT-1) as a predictor of preeclampsia in a pregnant woman by giving ajwa date
Visitas
3
Siti Husaidaha,b,
Autor para correspondencia
Sitihusaidah@mbp.ac.id

Corresponding author.
, Nasruddin A. Mappawarec, Aminuddind
a Department of Midwifery, Graduate School, Hasanuddin University, South Sulawesi, Indonesia
b Midwifery and Professional Midwifery Study Program, Institute of Health Mitra Bunda Batam, Riau Island, Indonesia
c Faculty of Medicine, Muslim University of Indonesia, South Sulawesi, Indonesia
d Faculty of Medicine, Hasanuddin University, South Sulawesi, Indonesia
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Tablas (4)
Table 1. Characteristics of study samples.
Table 2. Wilcoxon test analysis result on changes in MAP, ROT, and Sflt-1 levels according to the Intervention group in pregnant women given ajwa dates.
Table 3. Wilcoxon test analysis result on changes in MAP, ROT, and Sflt-1 levels according to the Control group in pregnant women who are not given ajwa dates.
Table 4. Effect of mean arterial pressure (MAP), Rollover test (ROT), and Sflt-1 level in the intervention and control groups using the logistic regression test.
Mostrar másMostrar menos
Abstract
Objective

This study aims to determine a change in mean arterial pressure (MAP), rollover test (ROT) and sFlt-1 level as a predictor of preeclampsia in an at-risk pregnant woman by giving ajwa dates.

Methods

This research has been conducted at RSIA Sitti Khadijah 1 Makassar with a quasi-experimental method and prospective cohort using a pre–post control design test. The research subjects have consisted of 30 at-risk pregnant women given ajwa dates and ten risk-pregnant women who are not given ajwa dates. This research has been conducted for eight weeks. The intervention group is given 100g/day while the control group is given pregnancy nutrition counseling three times/week. Blood samples have been taken two times, 20 weeks gestation (pre-test), and 28 weeks gestation (post-test). Data are analyzed by using Wilcoxon and Manova Tests.

Results

Wilcoxon test results in the pre–post intervention group have shown a decrease in the value of MAP (98.90–85.03), ROT (30.13–10.07), and SFLT-1 level (4.02–1.72) with sig. P<0.05, while the control group has obtained an increase in MAP values (96.70–102.30), ROT (30.40–30.00) and SFLT-1 levels (3.74–4.37) which are significant P>0.05. The logistic regression test has shown a MAP value of 0.005<0.05, which means the MAP has a prognostic value for risk-pregnant women of preeclampsia.

Conclusion

It can be concluded that there is a change of the decrease in the value of MAP, ROT, and SFLT-1 level in at-risk pregnant women of preeclampsia by giving ajwa dates at RSIA Sitti Khadijah 1 Makassar. It is expected that at-risk pregnant women regularly consume Ajwa dates to avoid preeclampsia.

Keywords:
Preeclampsia
Mean arterial pressure
Roll-over test

Artículo

Opciones para acceder a los textos completos de la publicación Enfermería Clínica
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Suscribirse
Suscribirse a:

Enfermería Clínica

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 19,34 €

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.enfcli.2019.07.022
No mostrar más